Skip to main content

Table 1 Reasons for exclusion in 937 out of 2505 men screened

From: Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

Reason

n

%

LEAD not confirmed

277

11.1

Patient unwilling

248

9.9

Lipid-modifying agent

87

3.5

Blood test results*

64

2.6

Renal or hepatic disease

45

1.8

Other significant disease

36

1.4

Unstable angina

17

0.7

Died before trial entry

15

0.6

Malignant disease

16

0.6

Other, unknown

132

5.3

Total

937

37.4

  1. *At screening (eg raised creatinine).
Back to article page

Trials

ISSN: 1745-6215